Partnership leverages Tenacia's expertise in central nervous system (CNS) drug development and commercialization to accelerate U.S. and global development of RAP-219 Tenacia obtains exclusive rights ...

Partnership leverages Tenacia’s expertise in central nervous system (CNS) drug development and commercialization to accelerate U.S. and global development of RAP-219 Tenacia obtains exclusive rights ...

A first-in-human trial shows the feasibility and safety of delivering placenta-derived stem cells during prenatal ...

To date, there are no regenerative stem cell products commercially available to treat diseases in utero. In-utero treatment ...

Stem cell therapy performed on babies in the womb could reverse brain abnormalities linked to a severe birth defect, experts have said. Spina bifida occurs when a baby’s spine fails to develop fully ...

World Population Prospects 2024: Summary of Results adopts the analytical framework of the demographic transition—the historic shift towards longer lives and smaller families—approximated here by the ...